The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virus

被引:0
|
作者
O. V. Masalova
E. I. Lesnova
L. N. Shingarova
V. L. Tunitskaya
T. I. Ulanova
A. N. Burkov
A. A. Kushch
机构
[1] Ministry of Health and Social Development of the Russian Federation,Ivanovsky Institute of Virology
[2] Russian Academy of Sciences,Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry
[3] Russian Academy of Sciences,Engelhardt Institute of Molecular Biology
[4] NPO Diagnostic Systems Ltd.,undefined
来源
Molecular Biology | 2012年 / 46卷
关键词
hepatitis C virus; nonstructural protein NS3; transfection; DNA immunization; recombinant protein; immune response; regulatory T cells; granulocyte macrophage colony-stimulating factor;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatitis C is related to the most important socially significant human infectious diseases. However, there is no vaccine for the hepatitis C virus. The nonstructural protein NS3 of the hepatitis C virus (HCV), which is synthesyzed in the infected cells and it displays protease, NTPase, and helicase enzymatic activities, is one of the possible components of the vaccine. The connection between the effectiveness of the T-cell response to NS3 epitopes and the spontaneous resolution of acute hepatitis C has been shown. The purpose of this work was to compare the immune response of mice to the inoculation of the nucleotide and amino acid sequences of HCV NS3 and their combination, as well as to evaluate the adjuvant activity of the DNA encoding of granulocyte macrophage colony-stimulating factor (GM-CSF) and the influence of regulatory T cells on the effectiveness of the immune response. The maximum anti-HCV NS3 antibody level in the serum (up to 1: 640000) induced the recombinant rNS3 protein introduced with aluminum hydroxide. The most intensive cellular immune response was observed after the simultaneous administration of rNS3 and DNAs encoding full-size NS3 and GM-CSF. A high level of lymphocyte proliferation, accumulation of IFN-γ-secreting cells, and IFN-γ/IL-2 release in response to the stimulators (NS3 antigens of different compositions) were observed in this group of mice. It has been established that the in vitro suppression of regulatory T cells leads to a statistically significant increase in the secretion of IFN-γ. Thus, the simultaneous application of rNS3, along with the DNAs encoding full-size NS3 and GM-CSF, is a promising approach to the development of hepatitis C vaccine. The expediency of adding regulatory T-cell inhibitors in the vaccine composition will be clear after special studies.
引用
收藏
页码:473 / 480
页数:7
相关论文
共 12 条
  • [1] The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virus
    Masalova, O. V.
    Lesnova, E. I.
    Shingarova, L. N.
    Tunitskaya, V. L.
    Ulanova, T. I.
    Burkov, A. N.
    Kushch, A. A.
    MOLECULAR BIOLOGY, 2012, 46 (03) : 473 - 480
  • [2] Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein
    Zabaleta, Aintzane
    Llopiz, Diana
    Arribillaga, Laura
    Silva, Leyre
    Riezu-Boj, Jose Ignacio
    Lasarte, Juan Jose
    Borras-Cuesta, Francisco
    Prieto, Jesus
    Sarobe, Pablo
    MOLECULAR THERAPY, 2008, 16 (01) : 210 - 217
  • [3] Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene
    Lee, SW
    Cho, JH
    Sung, YC
    JOURNAL OF VIROLOGY, 1998, 72 (10) : 8430 - 8436
  • [4] DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response
    Jiao, X
    Wang, RYH
    Feng, Z
    Hu, G
    Alter, HJ
    Shih, JWK
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (01) : 18 - 26
  • [5] Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor
    Zhai, Yongzhen
    Zhou, Yan
    Li, Ximei
    Feng, Guohe
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 199 - 209
  • [6] Hepatitis C Virus NS3/NS4A DNA Vaccine Induces Multiepitope T Cell Responses in Rhesus Macaques Mimicking Human Immune Responses
    Kuhs, Krystle A. Lang
    Ginsberg, Arielle A.
    Yan, Jian
    Wiseman, Roger W.
    Khan, Amir S.
    Sardesai, Niranjan Y.
    O'Connor, David H.
    Weiner, David B.
    MOLECULAR THERAPY, 2012, 20 (03) : 669 - 678
  • [7] Structurally conserved amino acid W501 is required for RNA helicase activity but is not essential for DNA helicase activity of hepatitis C virus NS3 protein
    Kim, JW
    Seo, MY
    Shelat, A
    Kim, CS
    Kwon, TW
    Lu, HH
    Moustakas, DT
    Sun, J
    Han, JH
    JOURNAL OF VIROLOGY, 2003, 77 (01) : 571 - 582
  • [8] Hepatitis C Virus NS3/NS4A DNA Vaccine Induces Multiepitope T Cell Responses in Rhesus Macaques Mimicking Human Immune Responses (vol 20, pg 669, 2012)
    Kuhs, Krystle A. Lang
    Ginsberg, Arielle A.
    Yan, Jian
    Wiseman, Roger W.
    Khan, Amir S.
    Sardesai, Niranjan Y.
    O'Connor, David H.
    Weiner, David B.
    MOLECULAR THERAPY, 2012, 20 (05) : 1075 - 1075
  • [9] Modulation of humoral and cellular immune responses generated against hepatitis C virus core DNA vaccine by utilizing granulocyte monocyte-colony stimulating factor and interleukin-23 as immunological adjuvants
    Hartoonian, Christine
    Ebtekar, Massoumeh
    Karami, Ali
    Mahdavi, Mehdi
    Azadmanesh, Kayhan
    Yousefipour, Mehdi
    CYTOKINE, 2008, 43 (03) : 311 - 311
  • [10] THE NTPASE/HELICASE DOMAIN OF HEPATITIS C VIRUS NONSTRUCTURAL PROTEIN 3 (NS3) INHIBITS PKC FAMILY KINASES IN VITRO AND INDUCES PHENOTYPIC ALTERATIONS IN NIH 3T3 CELLS
    Hartjen, Philip
    Borowski, Peter
    HEPATOLOGY, 2008, 48 (04) : 766A - 766A